Skip to main content Scroll Top
Alzheimer’s disease and gut microbiota: a potential for prevention and treatment
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
16 March 2026
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE tests light stimulation on neurodegenerative diseases
23 May 2023
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
7 February 2025
2 July 2019

Alzheimer’s disease and gut microbiota: a potential for prevention and treatment

Clinical Trials on Alzheimer’s Disease Asia (CTAD Asia) 2019, Beijing
Read the article

Jacques Touchon, MD, PhD, Laura Auboyer, PhD, Johann Meunier, PhD, Laura Ceolin, PhD, François J. Roman, PhD, Rémy Burcelin, PhD, Guillaume Blivet, MS. Late Breaking Oral Communication.

Share this article